![Yoshihisa Sasou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Yoshihisa Sasou
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Director/Miembro de la Junta | 18/09/2013 | - |
Historial de carrera de Yoshihisa Sasou
Antiguos cargos conocidos de Yoshihisa Sasou.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MITSUBISHI TANABE PHARMA CORPORATION | Public Communications Contact | 19/08/2010 | - |
Estadísticas
Internacional
Japón | 2 |
Canadá | 2 |
Operativa
Public Communications Contact | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Mitsubishi Tanabe Pharma Corp.
![]() Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Yoshihisa Sasou
- Experiencia